Kahn Brothers’ Top Picks to Close 2014, as Founder Irving Kahn Passes at 109

It comes as no surprise to see Pfizer Inc. (NYSE:PFE) amongst Kahn Brothers Group’s top picks for the past quarter, with ownership of 1.88 million shares. After all, it is one of the most popular health care stocks amongst the hedge funds we track, with an 11.7% fund ownership rate. So far, the company’s bulls were proven right, as the stock has already gained around 11% year-to-date. Although Pfizer Inc. (NYSE:PFE)’s latest earnings results did not outperform estimates, numerous institutional investors remain optimistic regarding future performance. Last quarter, the stock was held by Ken Fisher, Cliff Asness, and Ric Dillon, to name just some of the company’s largest investors.

With a stake of 4.13 million shares, New York Times Co (NYSE:NYT) ranks as one of Kahn Brothers Group’s top picks for the fourth quarter. Although the hedge fund trimmed its holding by a mere 6% last quarter, its bullish stance towards the company seems unaltered. After all, the fund has held a significant amount of shares for several years and has certainly not regretted the decision. From 2010 to the end of 2014, the stock gained 71% and year-to-date, the stock has already climbed approximately 6%. New York Times Co (NYSE:NYT) is backed by James H. Litinsky’s JHL Capital Group, which owned 9.6 million shares and is thus one of the company’s largest institutional investors at the end of 2014. Billionaire hedge fund managers such as Jim Simons and Ken Griffin also boast the stock amongst their equity holdings.

Disclosure: None